Hostname: page-component-586b7cd67f-t7czq Total loading time: 0 Render date: 2024-11-24T23:38:32.276Z Has data issue: false hasContentIssue false
  • English
  • Français

HTLV-I Associated Myelopathy: An Endemic Disease of Canadian Aboriginals of the Northwest Pacific Coast

Published online by Cambridge University Press:  18 September 2015

J.F. Oger Joël ,
H. Werker Denise ,
J. Foti Dean  and
A. Dekaban Gregory
J.F. Oger Joël*
Affiliation:
Division of Neurology, Department of Medicine, University of British Columbia, Vancouver, (J.J.F.O., D.J.F.); Department of Health Care and Epidemiology, University of British Columbia, Vancouver, (D.H.W.); Immunology Group, John P. Robarts Research Institute, London, (G.A.D.)
H. Werker Denise*
Affiliation:
Division of Neurology, Department of Medicine, University of British Columbia, Vancouver, (J.J.F.O., D.J.F.); Department of Health Care and Epidemiology, University of British Columbia, Vancouver, (D.H.W.); Immunology Group, John P. Robarts Research Institute, London, (G.A.D.)
J. Foti Dean*
Affiliation:
Division of Neurology, Department of Medicine, University of British Columbia, Vancouver, (J.J.F.O., D.J.F.); Department of Health Care and Epidemiology, University of British Columbia, Vancouver, (D.H.W.); Immunology Group, John P. Robarts Research Institute, London, (G.A.D.)
A. Dekaban Gregory*
Affiliation:
Division of Neurology, Department of Medicine, University of British Columbia, Vancouver, (J.J.F.O., D.J.F.); Department of Health Care and Epidemiology, University of British Columbia, Vancouver, (D.H.W.); Immunology Group, John P. Robarts Research Institute, London, (G.A.D.)
*
University Hospital (UBC site), 2211 Wesbrook Mall, Vancouver, British Columbia V6T 2B5
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Human T-cell lymphotropic virus type 1 (HTLV-I) is responsible for HTLV-I associated myelopathy or tropical spastic paraparesis (HAM/TSP) and for adult T-cell leukemia/lymphoma (ATLL). Both diseases have been well described in individuals living in Japan, West Indies, Seychelles Islands and Columbia where infection with HTLV-I is considered endemic and in persons whose descendants originated from these endemic areas. We report here 4 cases of HAM/TSP in 4 natives from 4 different tribal groups from British Columbia (B.C.). These are the first case reports of HTLV-I linked diseases found among North American Aboriginals. Possible routes of infection for HTLV-I infection included sexual transmission, breast feeding, blood transfusions and IV drug use. The seroprevalence of HTLV-I in North American Native population is unknown and we suggest that it is endemic in this ethnic group.

Type
Research Article
Information
Canadian Journal of Neurological Sciences , Volume 20 , Issue 4 , November 1993 , pp. 302 - 306
Copyright
Copyright © Canadian Neurological Sciences Federation 1993

References

REFERENCES

1.Román, GC.The neuroepidemioplogy of Tropical spatie paraparesis Ann Neurol 1988; 23 (Suppl): S113–S120.Google Scholar
2.Osame, M, Matsamuto, M, Usuka, A, et al. Chronic progressive myelopathy associated with elevated antibodies to HTLV-I and adult T-cell leukemia-like cells. Ann Neurol 1987; 21: 117–122.Google Scholar
3.Vernant, J-C, Maurs, L, Gout, O, et al. HTLV-I associated tropical spastic paraparesis in Martinique: a reappraisal. Ann Neurol 1988: 23 (Suppl): S133–S135.Google Scholar
4.Gessain, A, Barin, F, Vernant, JC, et al. Antibodies to human T-lym-photrophic virus type 1 in patients with tropical spastic paraparesis. Lancet 1985; ii: 407–410.Google Scholar
5.McKendall, RR, Oas, J.Lairniore, MD.HTLV-I associated myelopathy endemic in Texas-born residents and isolation of virus from CSF cells. Neurology 1991; 41: 831–836.Google Scholar
6.Power, C, Weinshenker, BG, Dekaban, GA, et al. HTLV-I associated myelopathy in Canada. Can J Neurol Sci 1989; 16: 330–335.Google Scholar
7.Dekaban, G, Werker, D, Foti, D, et al. HTLV-I infection associated with disease in three aboriginal indian families from British Columbia: a serological and PCR analysis; Submitted.Google Scholar
8.Gessain, A, Barin, F, Vernant, JC, et al. Antibodies to human T-lym-photropic virus type-1 in patients with tropical spastic paraparosis. Lancet 1985; 2: 407–410.CrossRefGoogle Scholar
9.Iwasaki, Y.Human T cell leukemia virus type 1 infection and chronic myelopathy. Brain Pathology 1993; 3: 1–10.CrossRefGoogle ScholarPubMed
10.Jacobson, S, Gupta, A, Mattson, D, Mingioli, E, McFarlin, DE.Immunological studies in tropical spastic paraparesis. Ann Neurol 1990; 27: 149–156.Google Scholar
11.McKendall, RR, Oas, J, Lairmore, MD.HTLV-1 associated myelopathy endemic in Texas-born residents and isolation of virus from CSF cells. Neurology 1991; 41: 831–836.CrossRefGoogle ScholarPubMed
12.Osame, M, Janssen, R, Kubota, H, et al. Nationwide survey of HTLV-1-associated myelopathy in Japan: association with blood transfusion. Ann Neurol 1990; 28; 50–56.CrossRefGoogle ScholarPubMed
13.Williams, AE, Fang, CE, Slamon, DJ, et al. Seroprevalence and epidemiological correlates of HTLV-1 infection in U.S. blood donors. Science 1988; 240: 643–646.Google Scholar
14.Sheremata, W, DeFreitas, E, Sazant, A.TSP in the United Slates: a study of Florida cases and relationship to multiple sclerosis. In: Roman, GC, Vernant, JC, Osama, M, eds. HTLV-I and the nervous system. New York: Alan Liss, 1989; 185–192.Google Scholar
15.Sadovnick, AD, Ebers, GC.Epidemiology of multiple sclerosis: a critical overview. Can J Neurol Sci 1993; 20: 17–29.Google Scholar
16.Dekaban, GA, Hudson, AJ, Rice, GPA.Absence of HTLV-I and HTLV-II proviral genome in the brains of patients with multiple sclerosis and amyotrophic lateral sclerosis. Can J Neurol Sci 1992; 19: 458–461.Google Scholar
17.Poser, C, Paty, D, Scheinberg, L, et al. New diagnostic criteria for multiple sclerosis. Ann Neurol 1983; 13: 227–231.Google Scholar
18.Schumacher, GA, Beebe, RF, Kibler, R, et al. Problems in experimental trials of therapy in multiple sclerosis: report by the panel of evaluation of experimental trials of therapy in multiple sclerosis. Ann NY Acad Sci 1965; 122: 522–568.CrossRefGoogle Scholar
19.Kajiwama, W, Kashiwagi, S, Ikematsu, H, et al. Intrafamilial transmission of adult T cell leukemia virus. J Infect Dis 1986; 154: 851–857.CrossRefGoogle Scholar
20.Manns, A, Blattner, WA.The epidemiology of the human T-cell lymphotrophic virus type I and type II. Transfusion 1991; 31: 67–75.CrossRefGoogle ScholarPubMed
21.Salazar-Grueso, EF, Holzer, TJ, Gutierrez, RA, et al. Familial spastic paraparesis syndrome associated with HTLV-I infection. New England J Med 1990; 323: 732–737.Google Scholar
22.Dekaban, GA, Inwood, M.Waters, D, Droulin, J, Teitel, J.Absence of HTLV-I/II in an Ontario hemophillia population, Canada. Transfusion. In Press.Google Scholar
23.Khabbaz, RF, Onorato, IM, Cannon, RO, et al. Seroprevalence of HTLV-I and HTLV-II among intravenous drug users and persons in clinics for sexually transmitted diseases. N Engl J Med 1992; 326: 375–380.CrossRefGoogle ScholarPubMed
24.Statistics Canada: Number of natives in British Columbia answering to a single ancestry and stating they are natives. Data from Canada 1991 census.Google Scholar
25.Poser, CM, Román, GC, Vernant, J-C.Multiple sclerosis or HTLV-Imyelitis? Neurology 1990; 40: 1020–1022.Google Scholar
26.CDC and USPHS Working group: guidelines for counseling persons infected with HTLV-I and HTLV-II Ann Int Med 1993; 118: 448–454.Google Scholar